Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

2014 Mid-Term Performance Review - Medical Equipment and Infrastructure
|
2015
2013 Mid-Term Performance Review - Medical Equipment and Infrastructure
|
2014
2011 Mid-Term Performance Review - Medical Equipment and Infrastructure
|
2011
2010 Mid-Term Performance Review - Medical Equipment
|
2010
2009 Mid-Term Performance Review - Medical Equipment
|
2009
2008 Mid-Term Performance Review - Medical Equipment
|
2008

 End chart zoom
2012 Mid-Term Performance Review - Medical Equipment and Infrastructure 2012 Mid-Term Performance Review - Medical Equipment and Infrastructure
* A page refresh may be necessary to see the updated image

2012 Mid-Term Performance Review - Medical Equipment and Infrastructure

 
December 14, 2012

The "2012 Mid-Term Performance Review: Medical Equipment & Infrastructure" report profiles medical equipment, imaging, and infrastructure vendors, providing a detailed look at the performance of each company's product line for the past 12 months.

Reflecting the customer voice, this report is a summary of performance data collected from healthcare professionals about the vendors they use.

Facts about the report:

  • 4,371 - Total number of provider evaluations included in this report
  • 201 - Total number of medical equipment products rated in this report
  • 6 - Total number of infrastructure products rated in this report

Preview the sample above or download the report to see how your vendors perform.

author - Robert Ellis
Project Manager
Robert Ellis
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

​